JPH0326165B2 - - Google Patents
Info
- Publication number
- JPH0326165B2 JPH0326165B2 JP58181628A JP18162883A JPH0326165B2 JP H0326165 B2 JPH0326165 B2 JP H0326165B2 JP 58181628 A JP58181628 A JP 58181628A JP 18162883 A JP18162883 A JP 18162883A JP H0326165 B2 JPH0326165 B2 JP H0326165B2
- Authority
- JP
- Japan
- Prior art keywords
- hydrocarbon group
- carbon atoms
- vesicles
- ammonium
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 claims description 25
- 125000001183 hydrocarbyl group Chemical group 0.000 claims description 21
- 125000004432 carbon atom Chemical group C* 0.000 claims description 18
- 239000004094 surface-active agent Substances 0.000 claims description 18
- -1 Phosphate ester salt Chemical class 0.000 claims description 14
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 5
- 229910019142 PO4 Inorganic materials 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 239000010452 phosphate Substances 0.000 claims description 4
- 150000005622 tetraalkylammonium hydroxides Chemical class 0.000 claims description 4
- 239000004475 Arginine Substances 0.000 claims description 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 3
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 3
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 3
- 239000004472 Lysine Substances 0.000 claims description 3
- 229910052783 alkali metal Inorganic materials 0.000 claims description 3
- 150000001340 alkali metals Chemical class 0.000 claims description 3
- 125000002947 alkylene group Chemical group 0.000 claims description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 3
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 3
- 125000002252 acyl group Chemical group 0.000 claims description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 2
- WZEMSIKSCALWJZ-UHFFFAOYSA-N azane;ethanol Chemical group N.CCO.CCO WZEMSIKSCALWJZ-UHFFFAOYSA-N 0.000 claims 1
- ZXVOCOLRQJZVBW-UHFFFAOYSA-N azane;ethanol Chemical group N.CCO ZXVOCOLRQJZVBW-UHFFFAOYSA-N 0.000 claims 1
- KQQCTWHSWXCZHB-UHFFFAOYSA-N azane;propan-2-ol Chemical group N.CC(C)O KQQCTWHSWXCZHB-UHFFFAOYSA-N 0.000 claims 1
- OHMBHFSEKCCCBW-UHFFFAOYSA-N hexane-2,5-diol Chemical group CC(O)CCC(C)O OHMBHFSEKCCCBW-UHFFFAOYSA-N 0.000 claims 1
- 125000005207 tetraalkylammonium group Chemical group 0.000 claims 1
- DZLFLBLQUQXARW-UHFFFAOYSA-N tetrabutylammonium Chemical compound CCCC[N+](CCCC)(CCCC)CCCC DZLFLBLQUQXARW-UHFFFAOYSA-N 0.000 claims 1
- CBXCPBUEXACCNR-UHFFFAOYSA-N tetraethylammonium Chemical compound CC[N+](CC)(CC)CC CBXCPBUEXACCNR-UHFFFAOYSA-N 0.000 claims 1
- QEMXHQIAXOOASZ-UHFFFAOYSA-N tetramethylammonium Chemical group C[N+](C)(C)C QEMXHQIAXOOASZ-UHFFFAOYSA-N 0.000 claims 1
- GJSGYPDDPQRWPK-UHFFFAOYSA-N tetrapentylammonium Chemical compound CCCCC[N+](CCCCC)(CCCCC)CCCCC GJSGYPDDPQRWPK-UHFFFAOYSA-N 0.000 claims 1
- OSBSFAARYOCBHB-UHFFFAOYSA-N tetrapropylammonium Chemical compound CCC[N+](CCC)(CCC)CCC OSBSFAARYOCBHB-UHFFFAOYSA-N 0.000 claims 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-O triethanolammonium Chemical group OCC[NH+](CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-O 0.000 claims 1
- 238000000034 method Methods 0.000 description 17
- 239000000243 solution Substances 0.000 description 16
- 239000002502 liposome Substances 0.000 description 14
- 239000000126 substance Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 239000012528 membrane Substances 0.000 description 6
- 239000003814 drug Substances 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000003937 drug carrier Substances 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 238000005481 NMR spectroscopy Methods 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 150000007514 bases Chemical class 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 150000003904 phospholipids Chemical class 0.000 description 3
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- SJZZDLZBGLQGCG-UHFFFAOYSA-N 2-[bis(2-hydroxyethyl)amino]ethanol;dioctadecyl hydrogen phosphate Chemical compound OCCN(CCO)CCO.CCCCCCCCCCCCCCCCCCOP(O)(=O)OCCCCCCCCCCCCCCCCCC SJZZDLZBGLQGCG-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 229940041181 antineoplastic drug Drugs 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000001678 irradiating effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- GBMTXDSKXXXLHM-ZSCHJXSPSA-N (2s)-2,6-diaminohexanoic acid;dioctadecyl hydrogen phosphate Chemical compound NCCCC[C@H](N)C(O)=O.CCCCCCCCCCCCCCCCCCOP(O)(=O)OCCCCCCCCCCCCCCCCCC GBMTXDSKXXXLHM-ZSCHJXSPSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- UJUWNSRXIGHHKM-UHFFFAOYSA-N 2-[bis(2-hydroxyethyl)amino]ethanol;didodecyl hydrogen phosphate Chemical compound OCC[NH+](CCO)CCO.CCCCCCCCCCCCOP([O-])(=O)OCCCCCCCCCCCC UJUWNSRXIGHHKM-UHFFFAOYSA-N 0.000 description 1
- ZJUUTZOYDQREOQ-UHFFFAOYSA-N C(O)CN.P(=O)(OCCCCCCCCCCCCCCCCCC)(OCCCCCCCCCCCCCCCCCC)O Chemical compound C(O)CN.P(=O)(OCCCCCCCCCCCCCCCCCC)(OCCCCCCCCCCCCCCCCCC)O ZJUUTZOYDQREOQ-UHFFFAOYSA-N 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- SRSLTXZRJNCQFO-UHFFFAOYSA-N N(CCO)CCO.P(=O)(OCCCCCCCCCCCCCCCCCC)(OCCCCCCCCCCCCCCCCCC)O Chemical compound N(CCO)CCO.P(=O)(OCCCCCCCCCCCCCCCCCC)(OCCCCCCCCCCCCCCCCCC)O SRSLTXZRJNCQFO-UHFFFAOYSA-N 0.000 description 1
- COQLPRJCUIATTQ-UHFFFAOYSA-N Uranyl acetate Chemical compound O.O.O=[U]=O.CC(O)=O.CC(O)=O COQLPRJCUIATTQ-UHFFFAOYSA-N 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- WFFZELZOEWLYNK-CLFAGFIQSA-N bis[(z)-octadec-9-enyl] hydrogen phosphate Chemical compound CCCCCCCC\C=C/CCCCCCCCOP(O)(=O)OCCCCCCCC\C=C/CCCCCCCC WFFZELZOEWLYNK-CLFAGFIQSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- OTOYAWQBIJQTRP-UHFFFAOYSA-N dihexadecyl phosphate;tris(2-hydroxyethyl)azanium Chemical compound OCC[NH+](CCO)CCO.CCCCCCCCCCCCCCCCOP([O-])(=O)OCCCCCCCCCCCCCCCC OTOYAWQBIJQTRP-UHFFFAOYSA-N 0.000 description 1
- FRXGWNKDEMTFPL-UHFFFAOYSA-N dioctadecyl hydrogen phosphate Chemical compound CCCCCCCCCCCCCCCCCCOP(O)(=O)OCCCCCCCCCCCCCCCCCC FRXGWNKDEMTFPL-UHFFFAOYSA-N 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- IYDGMDWEHDFVQI-UHFFFAOYSA-N phosphoric acid;trioxotungsten Chemical compound O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.OP(O)(O)=O IYDGMDWEHDFVQI-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- JSMHQMIPUOPQLR-UHFFFAOYSA-M sodium;dioctadecyl phosphate Chemical compound [Na+].CCCCCCCCCCCCCCCCCCOP([O-])(=O)OCCCCCCCCCCCCCCCCCC JSMHQMIPUOPQLR-UHFFFAOYSA-M 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000007447 staining method Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- WGTYBPLFGIVFAS-UHFFFAOYSA-M tetramethylammonium hydroxide Chemical compound [OH-].C[N+](C)(C)C WGTYBPLFGIVFAS-UHFFFAOYSA-M 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 230000007332 vesicle formation Effects 0.000 description 1
- 239000003021 water soluble solvent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
Description
æ¬çºæã¯ãã·ã¯ã«çšçµæç©ã«é¢ããæŽã«è©³çŽ°ã«
ã¯é·æéã«æž¡ã€ãŠå®å®ãªãã·ã¯ã«ã調補ããããš
ã®ã§ãããã·ã¯ã«çšçµæç©ã«é¢ããã çäœèã®éèŠãªæ§ææåã§ãããªã³è質ãç¹ã«
ã¬ã·ãã³ãæ°Žäžã«ãããŠãªããŸãŒã ãšåŒã°ããäº
éèäžç©ºå°èäœã圢æããããšã¯æ¢ã«ããç¥ãã
ãŠããããã®ãªããŸãŒã ã¯ãäžç©ºè質äºéèçã§
ãããå è ã«çš®ã ã®ååŠç©è³ªãå å«ããããšãã§
ããçãã®æ§é ãèµ€è¡çã«é ·äŒŒããŠãããããèµ€
è¡çã®ã¢ãã«ãããã¯çŽ°èã¢ãã«ãšããŠç 究ã
ããçäœèç 究ã«éèŠãªåœ¹å²ããæãããŠããã ãŸããè¿å¹Žããã®ãªããŸãŒã ã¯è¬ç©ã®çäœå é
æ¬äœãšããŠæ³šç®ãããŠãããããªãã¡ãå è ã«
çš®ã ã®ååŠç©è³ªãå å«ããããšã®ã§ãããªããŸãŒ
ã ã¯äžçš®ã®ã«ãã»ã«ãšèŠãªãããšãã§ããè¬ç©ã
ãªããŸãŒã å éšã«å ¥ããŠæäžãããšãè¬ç©ã®çäœ
å 代è¬ãæå¶ããé·æéçäœå ã«çã€ãŠè¬å¹ãæ
ç¶ãããïŒäŸãã°FEBS LettersïŒ36å·»ïŒïŒå·ïŒ
292é ïŒ1973幎ïŒãè¬ç©ã®å¯äœçšãäŸãã°ã¢ã¬ã«ã®
ãŒæ§ãæå¶ããããïŒäŸãã°FEBS LettersïŒ45
å·»ïŒïŒå·ïŒ71é ïŒ1974幎ïŒãè¬ç©ã®åçš®èåšãžã®
ååžãå€åãããããïŒäŸãã°Eur.J.Biochem.ïŒ
47å·»ïŒ179é ïŒ1974幎ïŒããšãå ±åãããŠããã ãã®æ§ã«ãªããŸãŒã ã¯è¬ç©ã®çäœå éæ¬äœãšã
ãŠåªããè«žæ§è³ªã瀺ãã®ã§ããããäžã§ãè¬ç©ã®
èåšååžãå€åããåŸãæ§è³ªã¯è¬ç©ãçŸæ£èåšãž
éžæçã«äœçšããåŸãå¯èœæ§ãæããŠãããæè¬
ãªããŸãŒã ã«ããæšçå¹æãšããŠæ³šç®ãéããŠã
ããäŸãã°å¶çå€ã¯ç现èã®ã¿ãªããå¥åº·ãªæ£åžž
现èã«ãäœçšããããå¯äœçšã®äŒŽãªãããšãå€ã
ããå¶çå€ããªããŸãŒã ã«å ¥ããŠæäžããããšã«
ããççµç¹ã«éžæçã«äœçšãããããšãã§ããã°
極ããŠæçšã§ãããšèãããããå®éããã®æ§ãª
è©Šã¿ãè¯å¥œãªçµæãåŸãŠããå ŽåãããïŒäŸãã°
æ¥æ¬çåŠäŒè¬æŒèŠæšéïŒïŒé ïŒ1976幎ïŒã ãŸãäºéèéšåã«ã¢ã«ãã«ã¢ãã³çã®é©åœãªäŒ
å°æ§ç©è³ªãå åãããªããŸãŒã ã®å 液ã«ç¬¬ïŒé ã€
ãªã³çã®å éå æ§ç©è³ªãããªããŸãŒã ã®å€æ¶²ã«ã¢
ã¹ã³ã«ãã³é žçã®å é žåæ§ç©è³ªãå ¥ããããã«å
ãç §å°ããããšã«ããäºéèã«å åããäŒå°æ§ç©
質ã®æ§è³ªã«å¿ããŠãç¹å®ã®ã€ãªã³ãå€æ¶²ããå 液
ã«æ¿çž®ããããšãå¯èœã§ãããããšãã°æµ·æ°Žãã
ããç¹å®ã®å çŽ ã€ãªã³ãååºããŠè³æºåããããš
ãã§ããããã®æ§ã«ãªããŸãŒã ã¯è¬ç©æäžçã«ç»
æçãªæ°ããææ³ããããããã®ã§ãããããªã
ãŸãŒã ã圢æãåŸããªã³è質ãçäœç±æ¥ç©è³ªã®ã
ããã®ååŠæ§é ã極ããŠå¶éãããŠããåçš®æ©èœ
ã®ä»äžã«äžäŸ¿ã§ããããšããŸããæ¯èŒçååŠçå®
å®æ§ã«ä¹ããããšçã®æ¬ ç¹ããã€ãã ããã§ããªã³è質ãªããŸãŒã ã®ãããå¶çŽãå
ãé€ãããã«ãæè¿åæçé¢æŽ»æ§å€ãåæãšãã
ãªããŸãŒã åå°èäœãããªãã¡ãã·ã¯ã«ã圢æã
ãããããã®ç 究ããªãããçŸåšãŸã§ã«æ°çš®é¡ã®
çé¢æŽ»æ§å€ã«ãã·ã¯ã«åœ¢æèœãããããšã確èªã
ããŠããããããŠãããçé¢æŽ»æ§å€ã®ãã·ã¯ã«ã
ãªããŸãŒã ãšåæ§ã«äºéèäžç©ºå°èäœæ§é ãæã
ãŠãããäžèšã®è¬ç©éæ¬äœçã«é©çšããåŸããã®
ã§ããã ããããªããããããçé¢æŽ»æ§å€ã®ãã·ã¯ã«
ã¯ãããããçé¢æŽ»æ§å€ã®ã¿ãæ°Žäžã«åæ£ãã
ããããã«äŸãã°è¶ é³æ³¢ãç §å°ããããšã«ããåŸ
ããããã®ã§ããã®ãã·ã¯ã«æ§é ãäžå®å®ã§ã
ããé·æéã®ä¿åã«èããããªãã®ãçŸç¶ã§ã
ããäŸãã°ãæ¬çºæã§çšãããžã¢ã«ãã«ãªã³é žãš
ã¹ãã«å¡©ã«ã€ããŠåäžã®æ¹æ³ã§ãã·ã¯ã«ãåŸãŠã
ãã·ã¯ã«æ§é ã¯æ°æ¥ä»¥å ã«å£ãã溶液ã¯çœæ¿è¥ã
ãã¯ã²ã«ç¶ãåããããã«ãªãã ãããã€ãŠãçé¢æŽ»æ§å€ãã·ã¯ã«ãè¬ç©éæ¬äœ
ããã®ä»ã®ç®çã«å©çšããããã«ã¯ãã®å®å®æ§ã
æ¹åããããšãäžå¯æ¬ ã§ããããã®ããã®æè¡ã
匷ãèŠæãããŠããã®ãçŸç¶ã§ãã€ãã æ¯ãçŸç¶ã«éã¿ãæ¬çºæè ãã¯é·æéã«æž¡ã€ãŠ
å®å®ãªãã·ã¯ã«ãåŸã¹ãéæç 究ããããªã€ãçµ
æããã·ã¯ã«åœ¢æèœãæããç¹å®ã®ãªã³é žãšã¹ã
ã«å¡©ãããçš®ã®çé¢æŽ»æ§å€åã³æ°Žãé åããç³»ã
ãåŸããã·ã¯ã«ã¯é·æéã«æž¡ã€ãŠå®å®ã«ååšãåŸ
ãããšãèŠåºããæ¬çºæãå®æããã ããªãã¡ãæ¬çºæã¯æ¬¡ã®ïŒæå(A)åã³(B)ãå«æ
ãã(A)æåãš(B)æåã®ééæ¯ã100ïŒïŒã100ïŒ
100ã§ãããã·ã¯ã«çšçµæç©ãæäŸãããã®ã§ã
ãã (A) äžè¬åŒïŒïŒ åŒäžãèšå·ã¯æ¬¡ã®ãã®ã瀺ãã R1åã³R2ïŒççŽ æ°ïŒã24ã®çåæ°ŽçŽ åº ïŒïŒã¢ã«ã«ãªéå±ãã¢ã«ã«ããŒã«ã¢ã³ã¢ããŠã ã
æ°Žé žåããã©ã¢ã«ãã«ã¢ã³ã¢ããŠã ããªãžã³ã
ã¢ã«ã®ãã³ããã¹ããžã³åã¯ã¢ã«ããªã³ã®ãã
ãã ã§è¡šãããããªã³é žãšã¹ãã«å¡© (B) äžçš®åã¯äºçš®ä»¥äžã®ã次ã®åŒ(a)ãïŒïœïŒ R3COOM (a) R3OSO3M (d) R3OïŒAOïŒoSO3M (e) R3OïŒAOïŒo (h) HOïŒAOïŒpïŒC3H6OïŒqïŒAOïŒr (j) R3COOïŒAOïŒoR6 (l) R3NHïŒâCH2ïŒâtCOOM ïŒïœïŒ åŒäžãåèšå·ã¯æ¬¡ã®ãã®ã瀺ãã R3ïŒççŽ æ°ïŒã36ã®çåæ°ŽçŽ åº R4åã³R5ïŒççŽ æ°ïŒã23ã®çåæ°ŽçŽ åº R6ïŒR7åã³R8ïŒæ°ŽçŽ åååã¯ççŽ æ°ïŒã24ã®ã¢
ã·ã«åº ïŒãã ããäžååäžã«R7ãšR8ãäž¡æ¹å«ãå Žåã
ãã®ãã¡å°ãªããšãäžæ¹ã¯æ°ŽçŽ ååã§ããïŒ R9åã³R10ïŒæ°ŽçŽ åååã¯ççŽ æ°ïŒã24ã®çåæ°Ž
çŽ åº ïŒãã ããå°ãªããšãäžæ¹ã¯æ°ŽçŽ ååã§ããïŒ R11ïŒR12åã³R13ïŒççŽ æ°ïŒã24ã®çåæ°ŽçŽ åº R14ïŒççŽ æ°ïŒã23ã®çåæ°ŽçŽ åº R15ïŒççŽ æ°ïŒã24ã®çåæ°ŽçŽ åºè¥ããã¯ããã
ãã·çåæ°ŽçŽ åº R16åã³R17ïŒççŽ æ°ïŒãïŒã®çåæ°ŽçŽ åºè¥ãã
ã¯ããããã·çåæ°ŽçŽ åºåã¯ãã³ãžã«åº ïŒççŽ æ°ïŒãïŒã®ã¢ã«ãã¬ã³åº ïŒïŒåèšãšåãæå³ãæãã ïœïŒïœåã³ïœïŒïŒåã¯ïŒã150ã®æŽæ° ïœïŒïœåã³ïœïŒïŒã150ã®æŽæ° ïœïŒïŒãïŒã®æŽæ° ã§è¡šããããååç©çŸ€ããéžã°ããçé¢æŽ»æ§å€ã (A)æåã§ãããªã³é žãšã¹ãã«å¡©ïŒïŒããã·ã¯
ã«ã圢æããããšã¯ãã§ã«å ¬ç¥ã§ãããäŸãã°åŠ
è¡éèªJ.Am.Chem.Soc.ïŒ101å·»ïŒ2231é ïŒ1979ïŒ
ã«å ±åãããŠãããããããªããã(A)æåã«(B)æ
åãé åããããšã«ãããã·ã¯ã«ãé·æéå®å®ã«
ä¿ãããããšã¯å šãç¥ãããŠãããããã®ããšã¯
æ¬çºæè ãã®ç 究ã«ãã€ãŠåããŠæããã«ããã
ãã®ã§ããã æ¬çºæã®(A)æåã§ãããªã³é žãšã¹ãã«å¡©ã¯ã次
ã®åŒïŒâ²ïŒ ïŒåŒäžãR1åã³R2ã¯åèšããæå³ãæããïŒ ã§è¡šãããããªã³é žãšã¹ãã«ãå¡©åºæ§ååç©ã§äž
åããããšã«ããåŸããããäžåã«çšããããå¡©
åºæ§ååç©ãšããŠã¯ã¢ã«ã«ãªéå±å«æå¡©åºæ§åå
ç©ïŒããšãã°æ°Žé žåãããªãŠã ïŒçé žãããªãŠã
ãªã©ïŒãã¢ã«ã«ããŒã«ã¢ãã³é¡ãæ°Žé žåããã©ã¢
ã«ãã«ã¢ã³ã¢ããŠã é¡ããªãžã³ãã¢ã«ã®ãã³ãã
ã¹ããžã³ããã³ã¢ã«ããªã³ã奜ãŸããããŸããã¢
ã«ã«ããŒã«ã¢ãã³é¡ã®äžã§ã¯ãã¢ã«ã«ããŒã«éšå
ãã¢ããšã¿ããŒã«ããžãšã¿ããŒã«ãããªãšã¿ããŒ
ã«ãã¢ããããããŒã«ããžãããããŒã«åã¯ããª
ãããããŒã«ã§ãããã®ãç¹ã«å¥œãŸãããæŽã«æ°Ž
é žåããã©ã¢ã«ãã«ã¢ã³ã¢ããŠã é¡ã®äžã§ã¯ã¢ã«
ãã«éšåãã¡ãã«ããšãã«ããããã«ãããã«å
ã¯ãã³ãã«ã§ãããã®ãç¹ã«å¥œãŸãããããã(A)
æåã®å ·äœäŸãšããŠã¯ããžãã·ã«ãªã³é žãšã¹ãã«
ããªãšã¿ããŒã«ã¢ãã³å¡©ããžããã·ã«ãªã³é žãšã¹
ãã«ããªãšã¿ããŒã«ã¢ãã³å¡©ããžãããµãã·ã«ãª
ã³é žãšã¹ãã«ããªãšã¿ããŒã«ã¢ãã³å¡©ããžãªã¬ã€
ã«ãªã³é žãšã¹ãã«ããªãšã¿ããŒã«ã¢ãã³å¡©ããžãª
ã¯ã¿ãã·ã«ãªã³é žãšã¹ãã«ãããªãŠã å¡©ããžãªã¯
ã¿ãã·ã«ãªã³é žãšã¹ãã«ã¢ããšã¿ããŒã«ã¢ãã³
å¡©ããžãªã¯ã¿ãã·ã«ãªã³é žãšã¹ãã«ãžãšã¿ããŒã«
ã¢ãã³å¡©ããžãªã¯ã¿ãã·ã«ãªã³é žãšã¹ãã«ãžã€ãœ
ãããããŒã«ã¢ãã³å¡©ããžãªã¯ã¿ãã·ã«ãªã³é žãš
ã¹ãã«æ°Žé žåããã©ã¡ãã«ã¢ã³ã¢ããŠã å¡©ããžãª
ã¯ã¿ãã·ã«ãªã³é žãšã¹ãã«ãªãžã³å¡©ããžãªã¯ã¿ã
ã·ã«ãªã³é žãšã¹ãã«ã¢ã«ã®ãã³å¡©ããžãªã¯ã¿ãã·
ã«ãªã³é žãšã¹ãã«ã¢ã«ããªã³å¡©çããããããšã
ã§ããããŸããããããªã³é žãšã¹ãã«å¡©ã®äºæ¬ã®
çæ°ŽéïŒR1ïŒR2ïŒã¯äžé£œåçµåãæãããã®ã§
ãããã€ãããªããã飜åã®çåæ°ŽçŽ åºã®æ¹ã奜
ãŸããã ãŸããæ¬çºæã®(B)æåã®çé¢æŽ»æ§å€ã¯ããã·ã¯
ã«ãå®å®ã«ä¿ã€äœçšãæãããã®ãšèããããŠã
ãããã®ãã¡(a)ã(g)ã¯é°ã€ãªã³æ§çé¢æŽ»æ§å€ã«ã
(h)ãïŒïœïŒã¯éã€ãªã³æ§çé¢æŽ»æ§å€ã«ãïŒïœïŒã
ïŒïœïŒã¯äž¡æ§çé¢æŽ»æ§å€ã«ããããå±ãããã®ã§
ãããããã(B)æåã®ãã¡ã(h)ãïŒïœïŒã®éã€ãª
ã³æ§çé¢æŽ»æ§å€ã«ä»å ããã¢ã«ãã¬ã³ãªããµã€ã
ãšããŠã¯ããšãã¬ã³ãªããµã€ãã奜ãŸããã æ¬çºæã®ãã·ã¯ã«çšçµæç©ã«ãããŠã¯ã(A)æå
ãš(B)æåã®é åééæ¯ãéèŠã§ããã(A)æåãš(B)
æåã®æ¯ã100ïŒïŒã100ïŒ100ã®ç¯å²ã§ããããš
ãå¿ èŠã§ãããé åééæ¯ããã®ç¯å²ãå€ããå Ž
åããã·ã¯ã«ãçæããªããåã¯ãã·ã¯ã«ãçæ
ããŠãäžå®å®ãšãªãã æ¬çºæã®ãã·ã¯ã«çšçµæç©ã補é ããã«ã¯å ¬ç¥
ã®æ¹æ³ã«åŸãã(A)æååã³(B)æåãããããäž¡æ¹
ã溶解ãåŸã溶åªã«æº¶è§£ããæ¹æããŠåäžãšãã
次ãã§æº¶åªãé€å»ããã°è¯ãã æ¯ãããŠåŸãããæ¬çºæã®ãã·ã¯ã«çšçµæç©ã
ããã·ã¯ã«ãåŸãã«ã¯ããã·ã¯ã«çšçµæç©ãæ°Žã«
æžæ¿ãããããã«è¶ é³æ³¢ãç §å°ããã°è¯ãããã
ããªããããã®æ¹æ³ã®ã¿ã«éãããäŸãã°æ°Žã«å¯
溶ãªãšã¿ããŒã«ã®æ§ãªæº¶åªã«ãã·ã¯ã«çšçµæç©ã
溶解ããããã®æ°Žæº¶æ¶²ãæ°Žäžã«åŒ·ãå°åºããæ¹æ³
ã氎溶æ§ã®çé¢æŽ»æ§å€ã§å¯æº¶åãã次ãã§éæã§
ãã®çé¢æŽ»æ§å€ãé€å»ããªããäœæããæ¹æ³çã
å©çšãããã·ã¯ã«æº¶æ¶²ãåŸãããšãã§ããã æ¬çºæã®ãã·ã¯ã«çšçµæç©ã«ãã調補ãããã
ã·ã¯ã«æº¶æ¶²ã¯ããã®æ¿åºŠãïŒã50ééïŒ ïŒä»¥äžå
ã«ïŒ ã§ç€ºãïŒã奜ãŸããããã奜ãŸããã¯ïŒã30
ïŒ ã§ããã溶液ã®ãã·ã¯ã«æ¿åºŠã50ïŒ ãè¶ãããš
ç²åºŠãé«ããªãéãããã·ã¯ã«ã®èª¿è£œå·¥çšåã³ã
ã·ã¯ã«ã®äœ¿çšæã«ãããŠäžéœåã®çããããšãã
ãããŸããæ¿åºŠãïŒïŒ æªæºã®å Žåã調補åã³äœ¿çš
ã«ã¯äœãæ¯éã¯ãªããããã·ã¯ã«æº¶æ¶²ã®èŒžéè²»ã
容åšã®é¢ã§ã³ã¹ããäžæããçµæžçã§ã¯ãªãã ãã®ããã«ããŠèª¿è£œããããã·ã¯ã«æº¶æ¶²äžã®ã
ã·ã¯ã«ã確èªããããã®çŸåšç¥ãããŠããæã確
ããªæ¹æ³ã¯ãã¬ãã€ãŽæè²æ³ã«ããé»åé¡åŸ®é¡èŠ³
å¯ã§ããããã¬ãã€ãŽæè²æ³ãšã¯ãªã³ã¿ã³ã°ã¹ã
ã³é žãé ¢é žãŠã©ããŒã«ã«ãã€ãŠãã·ã¯ã«ã圢æã
åŸãçé¢æŽ»æ§å€çã®èŠªæ°Žåºéšåã®é»åå¯åºŠãé«ã
ãããã®éšåãé»ãæè²ããæ¹æ³ã§ãããæ¬çºæ
ã«ãããŠã¯ãã®æ¹æ³ã«ãã€ãŠãã·ã¯ã«ã®çæã芳
å¯ããããã·ã¯ã«ãå«æãããã·ã¯ã«æº¶æ¶²ã¯éæ
ã§ãããã€æµåæ§ãè¯ããäžæ¹ãåèšååç©ãã
ã·ã¯ã«ãšã¯ãªããå€å±€ç¶æ§é ãšãªã€ãå Žåã®æº¶æ¶²
ã¯ã²ã«ç¶ã§çœæ¿ããã€æµåæ§ã極ããŠäžè¯ã§ã
ããåŸã€ãŠããã·ã¯ã«ã®å®å®æ§è©ŠéšïŒåŸè¿°ïŒã«ã
ããŠã¯ãããšãã°è¶ é³æ³¢æ³ã§ãã·ã¯ã«æº¶æ¶²ãäœ
ãã該溶液ã®éæ床ãšæµåæ§ãçµæçã«èŠ³å¯ãã
ããšã«ãããã·ã¯ã«çšçµæç©ã®å®å®æ§ãå€å®ãã
ããšãã§ããããŸãããã·ã¯ã«ã確èªããããã®
è£å©çãªç°¡äŸ¿æ³ãšããŠãæ žç£æ°å ±é³ŽïŒNMRïŒæ³
ãç¥ãããŠãããããªãã¡ã1Hâåã¯13CâNMR
ã®ç·©åæéãããã¯åžåç·å¹ ã¯ããã·ã¯ã«ã®å Žå
ãšããã§ãªãå Žåãšã§ã¯å€§ããç°ãªããã€ãŸãã
ãã·ã¯ã«ã®å Žåã¯ç·©åæéãé·ããªããåžåç·å¹
ã¯çãéããªããäžæ¹ããã·ã¯ã«ã§ãªãå Žåã¯ã
ç·©åæéãçãåžåç·å¹ ã¯åºããªããããããªã
ãNMRæ³ã§ã¯ããã·ã¯ã«ã®ç¹åŸŽã§ããäºéèæ§
é ã®ååšãçŽæ¥ç¢ºèªããããšãã§ããããã·ã¯ã«
ã®ååšã®å³å¯ãªç¢ºèªã®ããã«ã¯äžèšã®é»åé¡åŸ®é¡
ã«ãã芳å¯ãè¡ãã¹ãã§ããã 次ã«å®æœäŸã«ããæ¬çºæãæŽã«è©³ãã説æãã
ããæ¬çºæã¯ãããå®æœäŸã«éå®ããããã®ã§ã¯
ãªãã å®æœäŸ ïŒ è¡šâïŒã«ç€ºããªã³é žãšã¹ãã«å¡©ãšåçš®çé¢æŽ»æ§
å€ãšãããã·ã¯ã«çšçµæç©ã調補ãããã·ã¯ã«ã®
çæåã³ãã®å®å®æ§ã調ã¹ãããã®çµæãè¡šâïŒ
ã«ç€ºãã ããã·ã¯ã«çšçµæç©ã®èª¿è£œã ãšã¿ããŒã«ã«æº¶è§£ãããããªã³é žãšã¹ãã«å¡©10
ïœãšçé¢æŽ»æ§å€ïŒïœãæ··åããåäžã«ãªããŸã§æ¹
æããã次ãã§ãšããã¬ãŒã¿ãŒãçšããŠãšã¿ããŒ
ã«ãé€å»ãããã·ã¯ã«çšçµæç©ã®ç²æ«ãåŸãã ããã·ã¯ã«ã®çæåã³ãã®ç¢ºèªã åŸããããã·ã¯ã«çšçµæç©ã®ç²æ«10ïœã«å¯Ÿãã
æ°Ž90ïœãå ããŠæ¹æãããšç²çš ã§çœæ¿ããã²ã«ç¶
çµæç©ãšãªã€ãããã®ã²ã«ç¶çµæç©ã60âã«ä¿
ã¡ã100Wã25KHzã®è¶ é³æ³¢ãçŽïŒæéç §å°ããã
åŸããã溶液ã«ã€ããŠãé»åé¡åŸ®é¡èŠ³å¯ããããª
ãããã·ã¯ã«ã®çæã確èªããããªãããã·ã¯ã«
ã®çæããŠãããã®ã¯ãã»ãŒéæã§æµåæ§ã®è¯ã
溶液ãšãªã€ãŠããã ããã·ã¯ã«ã®å®å®æ§è©Šéšã äžèšã®åŠãããŠåŸããããã·ã¯ã«æº¶æ¶²ãïŒã«æ
é20âã®æ枩槜ã§ä¿åããïŒã«æçµéåŸã®ç¶æ ã
éæ床åã³æµåæ§ã®é¢ãã補é çŽåŸã®ç¶æ ãšæ¯èŒ
ããŠå®å®æ§ãè©äŸ¡ããããªãããã·ã¯ã«ã®çæå
ã³ãã®å®å®æ§ã«ã€ããŠã®è©äŸ¡åºæºã¯æ¬¡ã®éãã§ã
ãã ïŒä¿ååŸã®ç¶æ ã補é çŽåŸãšå šãå€ããããã
ã·ã¯ã«æ§é ãå®å šã«ä¿æãããŠããã ïŒè£œé çŽåŸã«æ¯ã¹ãããã«å¢ç²ããŠããçšåºŠã§
ããããã·ã¯ã«æ§é ãã»ãŒå®å šã«ä¿æãããŠã
ãã ïŒè£œé çŽåŸã®æº¶æ¶²ã®å¢ç²ãšçœæ¿ãèããããã·
ã¯ã«æ§é ãã»ãšãã©ååšããªãã ïŒè£œé çŽåŸã®æº¶æ¶²ãå®å šã«ã²ã«åçœæ¿ãããã·
ã¯ã«æ§é ã®ååšãå šãèªããããªãã ïŒïŒè¶ é³æ³¢ç §å°ãè¡ã€ãŠããã·ã¯ã«ãšã¯ãªããª
ãã
ã¯é·æéã«æž¡ã€ãŠå®å®ãªãã·ã¯ã«ã調補ããããš
ã®ã§ãããã·ã¯ã«çšçµæç©ã«é¢ããã çäœèã®éèŠãªæ§ææåã§ãããªã³è質ãç¹ã«
ã¬ã·ãã³ãæ°Žäžã«ãããŠãªããŸãŒã ãšåŒã°ããäº
éèäžç©ºå°èäœã圢æããããšã¯æ¢ã«ããç¥ãã
ãŠããããã®ãªããŸãŒã ã¯ãäžç©ºè質äºéèçã§
ãããå è ã«çš®ã ã®ååŠç©è³ªãå å«ããããšãã§
ããçãã®æ§é ãèµ€è¡çã«é ·äŒŒããŠãããããèµ€
è¡çã®ã¢ãã«ãããã¯çŽ°èã¢ãã«ãšããŠç 究ã
ããçäœèç 究ã«éèŠãªåœ¹å²ããæãããŠããã ãŸããè¿å¹Žããã®ãªããŸãŒã ã¯è¬ç©ã®çäœå é
æ¬äœãšããŠæ³šç®ãããŠãããããªãã¡ãå è ã«
çš®ã ã®ååŠç©è³ªãå å«ããããšã®ã§ãããªããŸãŒ
ã ã¯äžçš®ã®ã«ãã»ã«ãšèŠãªãããšãã§ããè¬ç©ã
ãªããŸãŒã å éšã«å ¥ããŠæäžãããšãè¬ç©ã®çäœ
å 代è¬ãæå¶ããé·æéçäœå ã«çã€ãŠè¬å¹ãæ
ç¶ãããïŒäŸãã°FEBS LettersïŒ36å·»ïŒïŒå·ïŒ
292é ïŒ1973幎ïŒãè¬ç©ã®å¯äœçšãäŸãã°ã¢ã¬ã«ã®
ãŒæ§ãæå¶ããããïŒäŸãã°FEBS LettersïŒ45
å·»ïŒïŒå·ïŒ71é ïŒ1974幎ïŒãè¬ç©ã®åçš®èåšãžã®
ååžãå€åãããããïŒäŸãã°Eur.J.Biochem.ïŒ
47å·»ïŒ179é ïŒ1974幎ïŒããšãå ±åãããŠããã ãã®æ§ã«ãªããŸãŒã ã¯è¬ç©ã®çäœå éæ¬äœãšã
ãŠåªããè«žæ§è³ªã瀺ãã®ã§ããããäžã§ãè¬ç©ã®
èåšååžãå€åããåŸãæ§è³ªã¯è¬ç©ãçŸæ£èåšãž
éžæçã«äœçšããåŸãå¯èœæ§ãæããŠãããæè¬
ãªããŸãŒã ã«ããæšçå¹æãšããŠæ³šç®ãéããŠã
ããäŸãã°å¶çå€ã¯ç现èã®ã¿ãªããå¥åº·ãªæ£åžž
现èã«ãäœçšããããå¯äœçšã®äŒŽãªãããšãå€ã
ããå¶çå€ããªããŸãŒã ã«å ¥ããŠæäžããããšã«
ããççµç¹ã«éžæçã«äœçšãããããšãã§ããã°
極ããŠæçšã§ãããšèãããããå®éããã®æ§ãª
è©Šã¿ãè¯å¥œãªçµæãåŸãŠããå ŽåãããïŒäŸãã°
æ¥æ¬çåŠäŒè¬æŒèŠæšéïŒïŒé ïŒ1976幎ïŒã ãŸãäºéèéšåã«ã¢ã«ãã«ã¢ãã³çã®é©åœãªäŒ
å°æ§ç©è³ªãå åãããªããŸãŒã ã®å 液ã«ç¬¬ïŒé ã€
ãªã³çã®å éå æ§ç©è³ªãããªããŸãŒã ã®å€æ¶²ã«ã¢
ã¹ã³ã«ãã³é žçã®å é žåæ§ç©è³ªãå ¥ããããã«å
ãç §å°ããããšã«ããäºéèã«å åããäŒå°æ§ç©
質ã®æ§è³ªã«å¿ããŠãç¹å®ã®ã€ãªã³ãå€æ¶²ããå 液
ã«æ¿çž®ããããšãå¯èœã§ãããããšãã°æµ·æ°Žãã
ããç¹å®ã®å çŽ ã€ãªã³ãååºããŠè³æºåããããš
ãã§ããããã®æ§ã«ãªããŸãŒã ã¯è¬ç©æäžçã«ç»
æçãªæ°ããææ³ããããããã®ã§ãããããªã
ãŸãŒã ã圢æãåŸããªã³è質ãçäœç±æ¥ç©è³ªã®ã
ããã®ååŠæ§é ã極ããŠå¶éãããŠããåçš®æ©èœ
ã®ä»äžã«äžäŸ¿ã§ããããšããŸããæ¯èŒçååŠçå®
å®æ§ã«ä¹ããããšçã®æ¬ ç¹ããã€ãã ããã§ããªã³è質ãªããŸãŒã ã®ãããå¶çŽãå
ãé€ãããã«ãæè¿åæçé¢æŽ»æ§å€ãåæãšãã
ãªããŸãŒã åå°èäœãããªãã¡ãã·ã¯ã«ã圢æã
ãããããã®ç 究ããªãããçŸåšãŸã§ã«æ°çš®é¡ã®
çé¢æŽ»æ§å€ã«ãã·ã¯ã«åœ¢æèœãããããšã確èªã
ããŠããããããŠãããçé¢æŽ»æ§å€ã®ãã·ã¯ã«ã
ãªããŸãŒã ãšåæ§ã«äºéèäžç©ºå°èäœæ§é ãæã
ãŠãããäžèšã®è¬ç©éæ¬äœçã«é©çšããåŸããã®
ã§ããã ããããªããããããçé¢æŽ»æ§å€ã®ãã·ã¯ã«
ã¯ãããããçé¢æŽ»æ§å€ã®ã¿ãæ°Žäžã«åæ£ãã
ããããã«äŸãã°è¶ é³æ³¢ãç §å°ããããšã«ããåŸ
ããããã®ã§ããã®ãã·ã¯ã«æ§é ãäžå®å®ã§ã
ããé·æéã®ä¿åã«èããããªãã®ãçŸç¶ã§ã
ããäŸãã°ãæ¬çºæã§çšãããžã¢ã«ãã«ãªã³é žãš
ã¹ãã«å¡©ã«ã€ããŠåäžã®æ¹æ³ã§ãã·ã¯ã«ãåŸãŠã
ãã·ã¯ã«æ§é ã¯æ°æ¥ä»¥å ã«å£ãã溶液ã¯çœæ¿è¥ã
ãã¯ã²ã«ç¶ãåããããã«ãªãã ãããã€ãŠãçé¢æŽ»æ§å€ãã·ã¯ã«ãè¬ç©éæ¬äœ
ããã®ä»ã®ç®çã«å©çšããããã«ã¯ãã®å®å®æ§ã
æ¹åããããšãäžå¯æ¬ ã§ããããã®ããã®æè¡ã
匷ãèŠæãããŠããã®ãçŸç¶ã§ãã€ãã æ¯ãçŸç¶ã«éã¿ãæ¬çºæè ãã¯é·æéã«æž¡ã€ãŠ
å®å®ãªãã·ã¯ã«ãåŸã¹ãéæç 究ããããªã€ãçµ
æããã·ã¯ã«åœ¢æèœãæããç¹å®ã®ãªã³é žãšã¹ã
ã«å¡©ãããçš®ã®çé¢æŽ»æ§å€åã³æ°Žãé åããç³»ã
ãåŸããã·ã¯ã«ã¯é·æéã«æž¡ã€ãŠå®å®ã«ååšãåŸ
ãããšãèŠåºããæ¬çºæãå®æããã ããªãã¡ãæ¬çºæã¯æ¬¡ã®ïŒæå(A)åã³(B)ãå«æ
ãã(A)æåãš(B)æåã®ééæ¯ã100ïŒïŒã100ïŒ
100ã§ãããã·ã¯ã«çšçµæç©ãæäŸãããã®ã§ã
ãã (A) äžè¬åŒïŒïŒ åŒäžãèšå·ã¯æ¬¡ã®ãã®ã瀺ãã R1åã³R2ïŒççŽ æ°ïŒã24ã®çåæ°ŽçŽ åº ïŒïŒã¢ã«ã«ãªéå±ãã¢ã«ã«ããŒã«ã¢ã³ã¢ããŠã ã
æ°Žé žåããã©ã¢ã«ãã«ã¢ã³ã¢ããŠã ããªãžã³ã
ã¢ã«ã®ãã³ããã¹ããžã³åã¯ã¢ã«ããªã³ã®ãã
ãã ã§è¡šãããããªã³é žãšã¹ãã«å¡© (B) äžçš®åã¯äºçš®ä»¥äžã®ã次ã®åŒ(a)ãïŒïœïŒ R3COOM (a) R3OSO3M (d) R3OïŒAOïŒoSO3M (e) R3OïŒAOïŒo (h) HOïŒAOïŒpïŒC3H6OïŒqïŒAOïŒr (j) R3COOïŒAOïŒoR6 (l) R3NHïŒâCH2ïŒâtCOOM ïŒïœïŒ åŒäžãåèšå·ã¯æ¬¡ã®ãã®ã瀺ãã R3ïŒççŽ æ°ïŒã36ã®çåæ°ŽçŽ åº R4åã³R5ïŒççŽ æ°ïŒã23ã®çåæ°ŽçŽ åº R6ïŒR7åã³R8ïŒæ°ŽçŽ åååã¯ççŽ æ°ïŒã24ã®ã¢
ã·ã«åº ïŒãã ããäžååäžã«R7ãšR8ãäž¡æ¹å«ãå Žåã
ãã®ãã¡å°ãªããšãäžæ¹ã¯æ°ŽçŽ ååã§ããïŒ R9åã³R10ïŒæ°ŽçŽ åååã¯ççŽ æ°ïŒã24ã®çåæ°Ž
çŽ åº ïŒãã ããå°ãªããšãäžæ¹ã¯æ°ŽçŽ ååã§ããïŒ R11ïŒR12åã³R13ïŒççŽ æ°ïŒã24ã®çåæ°ŽçŽ åº R14ïŒççŽ æ°ïŒã23ã®çåæ°ŽçŽ åº R15ïŒççŽ æ°ïŒã24ã®çåæ°ŽçŽ åºè¥ããã¯ããã
ãã·çåæ°ŽçŽ åº R16åã³R17ïŒççŽ æ°ïŒãïŒã®çåæ°ŽçŽ åºè¥ãã
ã¯ããããã·çåæ°ŽçŽ åºåã¯ãã³ãžã«åº ïŒççŽ æ°ïŒãïŒã®ã¢ã«ãã¬ã³åº ïŒïŒåèšãšåãæå³ãæãã ïœïŒïœåã³ïœïŒïŒåã¯ïŒã150ã®æŽæ° ïœïŒïœåã³ïœïŒïŒã150ã®æŽæ° ïœïŒïŒãïŒã®æŽæ° ã§è¡šããããååç©çŸ€ããéžã°ããçé¢æŽ»æ§å€ã (A)æåã§ãããªã³é žãšã¹ãã«å¡©ïŒïŒããã·ã¯
ã«ã圢æããããšã¯ãã§ã«å ¬ç¥ã§ãããäŸãã°åŠ
è¡éèªJ.Am.Chem.Soc.ïŒ101å·»ïŒ2231é ïŒ1979ïŒ
ã«å ±åãããŠãããããããªããã(A)æåã«(B)æ
åãé åããããšã«ãããã·ã¯ã«ãé·æéå®å®ã«
ä¿ãããããšã¯å šãç¥ãããŠãããããã®ããšã¯
æ¬çºæè ãã®ç 究ã«ãã€ãŠåããŠæããã«ããã
ãã®ã§ããã æ¬çºæã®(A)æåã§ãããªã³é žãšã¹ãã«å¡©ã¯ã次
ã®åŒïŒâ²ïŒ ïŒåŒäžãR1åã³R2ã¯åèšããæå³ãæããïŒ ã§è¡šãããããªã³é žãšã¹ãã«ãå¡©åºæ§ååç©ã§äž
åããããšã«ããåŸããããäžåã«çšããããå¡©
åºæ§ååç©ãšããŠã¯ã¢ã«ã«ãªéå±å«æå¡©åºæ§åå
ç©ïŒããšãã°æ°Žé žåãããªãŠã ïŒçé žãããªãŠã
ãªã©ïŒãã¢ã«ã«ããŒã«ã¢ãã³é¡ãæ°Žé žåããã©ã¢
ã«ãã«ã¢ã³ã¢ããŠã é¡ããªãžã³ãã¢ã«ã®ãã³ãã
ã¹ããžã³ããã³ã¢ã«ããªã³ã奜ãŸããããŸããã¢
ã«ã«ããŒã«ã¢ãã³é¡ã®äžã§ã¯ãã¢ã«ã«ããŒã«éšå
ãã¢ããšã¿ããŒã«ããžãšã¿ããŒã«ãããªãšã¿ããŒ
ã«ãã¢ããããããŒã«ããžãããããŒã«åã¯ããª
ãããããŒã«ã§ãããã®ãç¹ã«å¥œãŸãããæŽã«æ°Ž
é žåããã©ã¢ã«ãã«ã¢ã³ã¢ããŠã é¡ã®äžã§ã¯ã¢ã«
ãã«éšåãã¡ãã«ããšãã«ããããã«ãããã«å
ã¯ãã³ãã«ã§ãããã®ãç¹ã«å¥œãŸãããããã(A)
æåã®å ·äœäŸãšããŠã¯ããžãã·ã«ãªã³é žãšã¹ãã«
ããªãšã¿ããŒã«ã¢ãã³å¡©ããžããã·ã«ãªã³é žãšã¹
ãã«ããªãšã¿ããŒã«ã¢ãã³å¡©ããžãããµãã·ã«ãª
ã³é žãšã¹ãã«ããªãšã¿ããŒã«ã¢ãã³å¡©ããžãªã¬ã€
ã«ãªã³é žãšã¹ãã«ããªãšã¿ããŒã«ã¢ãã³å¡©ããžãª
ã¯ã¿ãã·ã«ãªã³é žãšã¹ãã«ãããªãŠã å¡©ããžãªã¯
ã¿ãã·ã«ãªã³é žãšã¹ãã«ã¢ããšã¿ããŒã«ã¢ãã³
å¡©ããžãªã¯ã¿ãã·ã«ãªã³é žãšã¹ãã«ãžãšã¿ããŒã«
ã¢ãã³å¡©ããžãªã¯ã¿ãã·ã«ãªã³é žãšã¹ãã«ãžã€ãœ
ãããããŒã«ã¢ãã³å¡©ããžãªã¯ã¿ãã·ã«ãªã³é žãš
ã¹ãã«æ°Žé žåããã©ã¡ãã«ã¢ã³ã¢ããŠã å¡©ããžãª
ã¯ã¿ãã·ã«ãªã³é žãšã¹ãã«ãªãžã³å¡©ããžãªã¯ã¿ã
ã·ã«ãªã³é žãšã¹ãã«ã¢ã«ã®ãã³å¡©ããžãªã¯ã¿ãã·
ã«ãªã³é žãšã¹ãã«ã¢ã«ããªã³å¡©çããããããšã
ã§ããããŸããããããªã³é žãšã¹ãã«å¡©ã®äºæ¬ã®
çæ°ŽéïŒR1ïŒR2ïŒã¯äžé£œåçµåãæãããã®ã§
ãããã€ãããªããã飜åã®çåæ°ŽçŽ åºã®æ¹ã奜
ãŸããã ãŸããæ¬çºæã®(B)æåã®çé¢æŽ»æ§å€ã¯ããã·ã¯
ã«ãå®å®ã«ä¿ã€äœçšãæãããã®ãšèããããŠã
ãããã®ãã¡(a)ã(g)ã¯é°ã€ãªã³æ§çé¢æŽ»æ§å€ã«ã
(h)ãïŒïœïŒã¯éã€ãªã³æ§çé¢æŽ»æ§å€ã«ãïŒïœïŒã
ïŒïœïŒã¯äž¡æ§çé¢æŽ»æ§å€ã«ããããå±ãããã®ã§
ãããããã(B)æåã®ãã¡ã(h)ãïŒïœïŒã®éã€ãª
ã³æ§çé¢æŽ»æ§å€ã«ä»å ããã¢ã«ãã¬ã³ãªããµã€ã
ãšããŠã¯ããšãã¬ã³ãªããµã€ãã奜ãŸããã æ¬çºæã®ãã·ã¯ã«çšçµæç©ã«ãããŠã¯ã(A)æå
ãš(B)æåã®é åééæ¯ãéèŠã§ããã(A)æåãš(B)
æåã®æ¯ã100ïŒïŒã100ïŒ100ã®ç¯å²ã§ããããš
ãå¿ èŠã§ãããé åééæ¯ããã®ç¯å²ãå€ããå Ž
åããã·ã¯ã«ãçæããªããåã¯ãã·ã¯ã«ãçæ
ããŠãäžå®å®ãšãªãã æ¬çºæã®ãã·ã¯ã«çšçµæç©ã補é ããã«ã¯å ¬ç¥
ã®æ¹æ³ã«åŸãã(A)æååã³(B)æåãããããäž¡æ¹
ã溶解ãåŸã溶åªã«æº¶è§£ããæ¹æããŠåäžãšãã
次ãã§æº¶åªãé€å»ããã°è¯ãã æ¯ãããŠåŸãããæ¬çºæã®ãã·ã¯ã«çšçµæç©ã
ããã·ã¯ã«ãåŸãã«ã¯ããã·ã¯ã«çšçµæç©ãæ°Žã«
æžæ¿ãããããã«è¶ é³æ³¢ãç §å°ããã°è¯ãããã
ããªããããã®æ¹æ³ã®ã¿ã«éãããäŸãã°æ°Žã«å¯
溶ãªãšã¿ããŒã«ã®æ§ãªæº¶åªã«ãã·ã¯ã«çšçµæç©ã
溶解ããããã®æ°Žæº¶æ¶²ãæ°Žäžã«åŒ·ãå°åºããæ¹æ³
ã氎溶æ§ã®çé¢æŽ»æ§å€ã§å¯æº¶åãã次ãã§éæã§
ãã®çé¢æŽ»æ§å€ãé€å»ããªããäœæããæ¹æ³çã
å©çšãããã·ã¯ã«æº¶æ¶²ãåŸãããšãã§ããã æ¬çºæã®ãã·ã¯ã«çšçµæç©ã«ãã調補ãããã
ã·ã¯ã«æº¶æ¶²ã¯ããã®æ¿åºŠãïŒã50ééïŒ ïŒä»¥äžå
ã«ïŒ ã§ç€ºãïŒã奜ãŸããããã奜ãŸããã¯ïŒã30
ïŒ ã§ããã溶液ã®ãã·ã¯ã«æ¿åºŠã50ïŒ ãè¶ãããš
ç²åºŠãé«ããªãéãããã·ã¯ã«ã®èª¿è£œå·¥çšåã³ã
ã·ã¯ã«ã®äœ¿çšæã«ãããŠäžéœåã®çããããšãã
ãããŸããæ¿åºŠãïŒïŒ æªæºã®å Žåã調補åã³äœ¿çš
ã«ã¯äœãæ¯éã¯ãªããããã·ã¯ã«æº¶æ¶²ã®èŒžéè²»ã
容åšã®é¢ã§ã³ã¹ããäžæããçµæžçã§ã¯ãªãã ãã®ããã«ããŠèª¿è£œããããã·ã¯ã«æº¶æ¶²äžã®ã
ã·ã¯ã«ã確èªããããã®çŸåšç¥ãããŠããæã確
ããªæ¹æ³ã¯ãã¬ãã€ãŽæè²æ³ã«ããé»åé¡åŸ®é¡èŠ³
å¯ã§ããããã¬ãã€ãŽæè²æ³ãšã¯ãªã³ã¿ã³ã°ã¹ã
ã³é žãé ¢é žãŠã©ããŒã«ã«ãã€ãŠãã·ã¯ã«ã圢æã
åŸãçé¢æŽ»æ§å€çã®èŠªæ°Žåºéšåã®é»åå¯åºŠãé«ã
ãããã®éšåãé»ãæè²ããæ¹æ³ã§ãããæ¬çºæ
ã«ãããŠã¯ãã®æ¹æ³ã«ãã€ãŠãã·ã¯ã«ã®çæã芳
å¯ããããã·ã¯ã«ãå«æãããã·ã¯ã«æº¶æ¶²ã¯éæ
ã§ãããã€æµåæ§ãè¯ããäžæ¹ãåèšååç©ãã
ã·ã¯ã«ãšã¯ãªããå€å±€ç¶æ§é ãšãªã€ãå Žåã®æº¶æ¶²
ã¯ã²ã«ç¶ã§çœæ¿ããã€æµåæ§ã極ããŠäžè¯ã§ã
ããåŸã€ãŠããã·ã¯ã«ã®å®å®æ§è©ŠéšïŒåŸè¿°ïŒã«ã
ããŠã¯ãããšãã°è¶ é³æ³¢æ³ã§ãã·ã¯ã«æº¶æ¶²ãäœ
ãã該溶液ã®éæ床ãšæµåæ§ãçµæçã«èŠ³å¯ãã
ããšã«ãããã·ã¯ã«çšçµæç©ã®å®å®æ§ãå€å®ãã
ããšãã§ããããŸãããã·ã¯ã«ã確èªããããã®
è£å©çãªç°¡äŸ¿æ³ãšããŠãæ žç£æ°å ±é³ŽïŒNMRïŒæ³
ãç¥ãããŠãããããªãã¡ã1Hâåã¯13CâNMR
ã®ç·©åæéãããã¯åžåç·å¹ ã¯ããã·ã¯ã«ã®å Žå
ãšããã§ãªãå Žåãšã§ã¯å€§ããç°ãªããã€ãŸãã
ãã·ã¯ã«ã®å Žåã¯ç·©åæéãé·ããªããåžåç·å¹
ã¯çãéããªããäžæ¹ããã·ã¯ã«ã§ãªãå Žåã¯ã
ç·©åæéãçãåžåç·å¹ ã¯åºããªããããããªã
ãNMRæ³ã§ã¯ããã·ã¯ã«ã®ç¹åŸŽã§ããäºéèæ§
é ã®ååšãçŽæ¥ç¢ºèªããããšãã§ããããã·ã¯ã«
ã®ååšã®å³å¯ãªç¢ºèªã®ããã«ã¯äžèšã®é»åé¡åŸ®é¡
ã«ãã芳å¯ãè¡ãã¹ãã§ããã 次ã«å®æœäŸã«ããæ¬çºæãæŽã«è©³ãã説æãã
ããæ¬çºæã¯ãããå®æœäŸã«éå®ããããã®ã§ã¯
ãªãã å®æœäŸ ïŒ è¡šâïŒã«ç€ºããªã³é žãšã¹ãã«å¡©ãšåçš®çé¢æŽ»æ§
å€ãšãããã·ã¯ã«çšçµæç©ã調補ãããã·ã¯ã«ã®
çæåã³ãã®å®å®æ§ã調ã¹ãããã®çµæãè¡šâïŒ
ã«ç€ºãã ããã·ã¯ã«çšçµæç©ã®èª¿è£œã ãšã¿ããŒã«ã«æº¶è§£ãããããªã³é žãšã¹ãã«å¡©10
ïœãšçé¢æŽ»æ§å€ïŒïœãæ··åããåäžã«ãªããŸã§æ¹
æããã次ãã§ãšããã¬ãŒã¿ãŒãçšããŠãšã¿ããŒ
ã«ãé€å»ãããã·ã¯ã«çšçµæç©ã®ç²æ«ãåŸãã ããã·ã¯ã«ã®çæåã³ãã®ç¢ºèªã åŸããããã·ã¯ã«çšçµæç©ã®ç²æ«10ïœã«å¯Ÿãã
æ°Ž90ïœãå ããŠæ¹æãããšç²çš ã§çœæ¿ããã²ã«ç¶
çµæç©ãšãªã€ãããã®ã²ã«ç¶çµæç©ã60âã«ä¿
ã¡ã100Wã25KHzã®è¶ é³æ³¢ãçŽïŒæéç §å°ããã
åŸããã溶液ã«ã€ããŠãé»åé¡åŸ®é¡èŠ³å¯ããããª
ãããã·ã¯ã«ã®çæã確èªããããªãããã·ã¯ã«
ã®çæããŠãããã®ã¯ãã»ãŒéæã§æµåæ§ã®è¯ã
溶液ãšãªã€ãŠããã ããã·ã¯ã«ã®å®å®æ§è©Šéšã äžèšã®åŠãããŠåŸããããã·ã¯ã«æº¶æ¶²ãïŒã«æ
é20âã®æ枩槜ã§ä¿åããïŒã«æçµéåŸã®ç¶æ ã
éæ床åã³æµåæ§ã®é¢ãã補é çŽåŸã®ç¶æ ãšæ¯èŒ
ããŠå®å®æ§ãè©äŸ¡ããããªãããã·ã¯ã«ã®çæå
ã³ãã®å®å®æ§ã«ã€ããŠã®è©äŸ¡åºæºã¯æ¬¡ã®éãã§ã
ãã ïŒä¿ååŸã®ç¶æ ã補é çŽåŸãšå šãå€ããããã
ã·ã¯ã«æ§é ãå®å šã«ä¿æãããŠããã ïŒè£œé çŽåŸã«æ¯ã¹ãããã«å¢ç²ããŠããçšåºŠã§
ããããã·ã¯ã«æ§é ãã»ãŒå®å šã«ä¿æãããŠã
ãã ïŒè£œé çŽåŸã®æº¶æ¶²ã®å¢ç²ãšçœæ¿ãèããããã·
ã¯ã«æ§é ãã»ãšãã©ååšããªãã ïŒè£œé çŽåŸã®æº¶æ¶²ãå®å šã«ã²ã«åçœæ¿ãããã·
ã¯ã«æ§é ã®ååšãå šãèªããããªãã ïŒïŒè¶ é³æ³¢ç §å°ãè¡ã€ãŠããã·ã¯ã«ãšã¯ãªããª
ãã
ãè¡šã
ãè¡šã
æ¯èŒäŸ ïŒ
è¡šâïŒã«ç€ºãããªã³é
žãšã¹ãã«å¡©10ïœãæ°Ž90ïœ
ã«æº¶è§£ããå®æœäŸïŒã®æ¹æ³ã«æºããŠãã·ã¯ã«ãç
æãããããããïŒã«æé20âã®æ枩槜ã§ä¿å
ããä¿ååŸã®ç¶æ ã調ã¹ããïŒçš®ã®ãªã³é žãšã¹ã
ã«å¡©ãã¹ãŠã®å Žåã«ãããŠãã·ã¯ã«ã¯çæãã
ããïŒã«æã®ä¿åã®åŸã¯æº¶æ¶²ãã²ã«ç¶ã§çœæ¿ãã
ãã·ã¯ã«æ§é ã倱ãããŠããã å®æœäŸ ïŒ ãžãªã¯ã¿ãã·ã«ãªã³é žãšã¹ãã«ããªãšã¿ããŒã«
ã¢ãã³å¡©ãšè¡šâïŒã«ç€ºãããçé¢æŽ»æ§å€ãçšãã
å®æœäŸïŒã®æ¹æ³ã«åŸã€ãŠãã·ã¯ã«çšçµæç©ã調補
ãã該çµæç©ããåŸããããã·ã¯ã«ã®å®å®æ§ã調
ã¹ãããã®çµæãè¡šâïŒã«ç€ºãã
ã«æº¶è§£ããå®æœäŸïŒã®æ¹æ³ã«æºããŠãã·ã¯ã«ãç
æãããããããïŒã«æé20âã®æ枩槜ã§ä¿å
ããä¿ååŸã®ç¶æ ã調ã¹ããïŒçš®ã®ãªã³é žãšã¹ã
ã«å¡©ãã¹ãŠã®å Žåã«ãããŠãã·ã¯ã«ã¯çæãã
ããïŒã«æã®ä¿åã®åŸã¯æº¶æ¶²ãã²ã«ç¶ã§çœæ¿ãã
ãã·ã¯ã«æ§é ã倱ãããŠããã å®æœäŸ ïŒ ãžãªã¯ã¿ãã·ã«ãªã³é žãšã¹ãã«ããªãšã¿ããŒã«
ã¢ãã³å¡©ãšè¡šâïŒã«ç€ºãããçé¢æŽ»æ§å€ãçšãã
å®æœäŸïŒã®æ¹æ³ã«åŸã€ãŠãã·ã¯ã«çšçµæç©ã調補
ãã該çµæç©ããåŸããããã·ã¯ã«ã®å®å®æ§ã調
ã¹ãããã®çµæãè¡šâïŒã«ç€ºãã
ãè¡šã
ãè¡šã
å®æœäŸ ïŒ
è¡šâïŒã«ç€ºãåèš15çš®é¡ã®ãªã³é
žãšã¹ãã«å¡©
ãšãå®æœäŸïŒã§çšããïŒçš®é¡ã®çé¢æŽ»æ§å€ããã
ããçµã¿åãããŠãå®æœäŸïŒã®æ¹æ³ã«æºããŠåèš
45çš®é¡ã®ãã·ã¯ã«çšçµæç©ã調補ãã該çµæç©ã
ãåŸããããã·ã¯ã«ã®å®å®æ§ã調ã¹ãã ãã®çµæãè¡šâïŒã«ç€ºãã
ãšãå®æœäŸïŒã§çšããïŒçš®é¡ã®çé¢æŽ»æ§å€ããã
ããçµã¿åãããŠãå®æœäŸïŒã®æ¹æ³ã«æºããŠåèš
45çš®é¡ã®ãã·ã¯ã«çšçµæç©ã調補ãã該çµæç©ã
ãåŸããããã·ã¯ã«ã®å®å®æ§ã調ã¹ãã ãã®çµæãè¡šâïŒã«ç€ºãã
ãè¡šã
å®æœäŸ ïŒ
ãžãªã¯ã¿ãã·ã«ãªã³é
žãšã¹ãã«ããªãšã¿ããŒã«
ã¢ãã³å¡©ãšå®æœäŸïŒã§çšããçé¢æŽ»æ§å€ãšããè¡š
âïŒã«ç€ºãé åæ¯çã§æ··åããå®æœäŸïŒã®æ¹æ³ã«
åŸã€ãŠåèš39çš®ã®ãã·ã¯ã«çµæç©ã調補ãããã
ã®çµæç©ã«ã€ããŠãå®æœäŸïŒãšåæ§ã«ããŠãã·ã¯
ã«çæåã³ãã®å®å®æ§ã調ã¹ãããã®çµæãè¡šâ
ïŒã«ç€ºãã
ã¢ãã³å¡©ãšå®æœäŸïŒã§çšããçé¢æŽ»æ§å€ãšããè¡š
âïŒã«ç€ºãé åæ¯çã§æ··åããå®æœäŸïŒã®æ¹æ³ã«
åŸã€ãŠåèš39çš®ã®ãã·ã¯ã«çµæç©ã調補ãããã
ã®çµæç©ã«ã€ããŠãå®æœäŸïŒãšåæ§ã«ããŠãã·ã¯
ã«çæåã³ãã®å®å®æ§ã調ã¹ãããã®çµæãè¡šâ
ïŒã«ç€ºãã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ æ¬¡ã®ïŒæå(A)åã³(B)ãå«æãã(A)æåãš(B)æ
åã®ééæ¯ã100ïŒïŒã100ïŒ100ã§ãããã·ã¯ã«
çšçµæç©ã (A) äžè¬åŒïŒïŒ åŒäžãèšå·ã¯æ¬¡ã®ãã®ã瀺ãã R1åã³R2ïŒççŽ æ°ïŒã24ã®çåæ°ŽçŽ åº ïŒïŒã¢ã«ã«ãªéå±ãã¢ã«ã«ããŒã«ã¢ã³ã¢ããŠ
ã ãæ°Žé žåããã©ã¢ã«ãã«ã¢ã³ã¢ããŠã ããªãž
ã³ãã¢ã«ã®ãã³ããã¹ããžã³åã¯ã¢ã«ããªã³ã®
ãããã ã§è¡šãããããªã³é žãšã¹ãã«å¡© (B) äžçš®åã¯äºçš®ä»¥äžã®ã次ã®åŒ(a)ãïŒïœïŒ R3COOM (a) R3OSO3M (d) R3OïŒAOïŒoSO3M (e) R3OïŒAOïŒo (h) HOïŒAOïŒpïŒC3H6OïŒqïŒAOïŒr (j) R3COOïŒAOïŒoR6 (l) R3NHïŒâCH2ïŒâtCOOM ïŒïœïŒ åŒäžãåèšå·ã¯æ¬¡ã®ãã®ã瀺ãã R3ïŒççŽ æ°ïŒã36ã®çåæ°ŽçŽ åº R4åã³R5ïŒççŽ æ°ïŒã23ã®çåæ°ŽçŽ åº R6ïŒR7åã³R8ïŒæ°ŽçŽ åååã¯ççŽ æ°ïŒã24ã®ã¢
ã·ã«åº ïŒãã ããäžååäžã«R7ãšR8ãäž¡æ¹å«ãå Žåã
ãã®ãã¡å°ãªããšãäžæ¹ã¯æ°ŽçŽ ååã§ããïŒ R9åã³R10ïŒæ°ŽçŽ åååã¯ççŽ æ°ïŒã24ã®çåæ°Ž
çŽ åº ïŒãã ããå°ãªããšãäžæ¹ã¯æ°ŽçŽ ååã§ããïŒ R11ïŒR12åã³R13ïŒççŽ æ°ïŒã24ã®çåæ°ŽçŽ åº R14ïŒççŽ æ°ïŒã23ã®çåæ°ŽçŽ åº R15ïŒççŽ æ°ïŒã24ã®çåæ°ŽçŽ åºè¥ããã¯ããã
ãã·çåæ°ŽçŽ åº R16åã³R17ïŒççŽ æ°ïŒãïŒã®çåæ°ŽçŽ åºè¥ãã
ã¯ããããã·çåæ°ŽçŽ åºåã¯ãã³ãžã«åº ïŒççŽ æ°ïŒãïŒã®ã¢ã«ãã¬ã³åº ïŒïŒåèšãšåãæå³ãæãã  ïŒïŒçŽã¢ã³ã¢ããŠã ã€ãªã³ã®å¯Ÿã€ãªã³ãšãªã
ã¢ããªã³ ïœïŒïœåã³ïœïŒïŒåã¯ïŒã150ã®æŽæ° ïœïŒïœåã³ïœïŒïŒã150ã®æŽæ° ïœïŒïŒãïŒã®æŽæ° ã§è¡šããããååç©çŸ€ããéžã°ããçé¢æŽ»æ§å€ã ïŒ (B)æåäžãåºïŒã«ãããã¢ã«ã«ããŒã«ã¢ã³ã¢
ããŠã ãã¢ããšã¿ããŒã«ã¢ã³ã¢ããŠã ããžãšã¿ã
ãŒã«ã¢ã³ã¢ããŠã ãããªãšã¿ããŒã«ã¢ã³ã¢ããŠ
ã ãã¢ãã€ãœãããããŒã«ã¢ã³ã¢ããŠã ããžã€ãœ
ãããããŒã«ã¢ã³ã¢ããŠã åã¯ããªã€ãœãããã
ãŒã«ã¢ã³ã¢ããŠã ã®ããããã§ãããããã©ã¢ã«
ãã«ã¢ã³ã¢ããŠã ãããã©ã¡ãã«ã¢ã³ã¢ããŠã ã
ããã©ãšãã«ã¢ã³ã¢ããŠã ãããã©ãããã«ã¢ã³
ã¢ããŠã ãããã©ããã«ã¢ã³ã¢ããŠã ãåã¯ãã
ã©ãã³ãã«ã¢ã³ã¢ããŠã ã®ããããã§ããç¹èš±è«
æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ãã·ã¯ã«çšçµæç©ã
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP58181628A JPS6072830A (ja) | 1983-09-29 | 1983-09-29 | ãã·ã¯ã«çšçµæç© |
GB08422629A GB2151203B (en) | 1983-09-29 | 1984-09-07 | Compositions for making vesicles |
FR8414761A FR2552666B1 (fr) | 1983-09-29 | 1984-09-26 | Compositions vesiculaires a base de sel de phosphate et d'agent tensio-actif |
DE19843435517 DE3435517A1 (de) | 1983-09-29 | 1984-09-27 | Vesikel bildende massen |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP58181628A JPS6072830A (ja) | 1983-09-29 | 1983-09-29 | ãã·ã¯ã«çšçµæç© |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6072830A JPS6072830A (ja) | 1985-04-24 |
JPH0326165B2 true JPH0326165B2 (ja) | 1991-04-10 |
Family
ID=16104098
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP58181628A Granted JPS6072830A (ja) | 1983-09-29 | 1983-09-29 | ãã·ã¯ã«çšçµæç© |
Country Status (4)
Country | Link |
---|---|
JP (1) | JPS6072830A (ja) |
DE (1) | DE3435517A1 (ja) |
FR (1) | FR2552666B1 (ja) |
GB (1) | GB2151203B (ja) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK86988A (da) * | 1987-02-25 | 1988-08-26 | Takeda Chemical Industries Ltd | Liposompraeparat og anvendelse deraf |
US4911928A (en) * | 1987-03-13 | 1990-03-27 | Micro-Pak, Inc. | Paucilamellar lipid vesicles |
JPH0720857B2 (ja) * | 1988-08-11 | 1995-03-08 | ãã«ã¢æ ªåŒäŒç€Ÿ | ãªããœãŒã ããã³ãã®è£œæ³ |
US6132763A (en) * | 1988-10-20 | 2000-10-17 | Polymasc Pharmaceuticals Plc | Liposomes |
WO1991016040A1 (en) * | 1990-04-18 | 1991-10-31 | Takeda Chemical Industries, Ltd. | Liposome composition |
DE4107153A1 (de) * | 1991-03-06 | 1992-09-10 | Gregor Cevc | Praeparat zur wirkstoffapplikation in kleinsttroepfchenform |
DE4107152C2 (de) * | 1991-03-06 | 1994-03-24 | Gregor Cevc | PrÀparate zur nichtinvasiven Verabreichung von Antidiabetica |
EP0550463B1 (en) * | 1990-09-06 | 1996-06-26 | S.C. Johnson & Son, Inc. | Stabilized liposome process and compositions containing them |
US5741518A (en) * | 1992-08-03 | 1998-04-21 | L'oreal | Composition composed of an aqueous dispersion of stabilized vesicles of nonionic amphiphilic lipids |
FR2694893A1 (fr) * | 1992-08-03 | 1994-02-25 | Oreal | Composition formée d'une dispersion aqueuse de vésicules de lipides amphiphiles non-ioniques stabilisées. |
FR2694884B1 (fr) * | 1992-08-03 | 1996-10-18 | Oreal | Composition formee d'une dispersion aqueuse de vesicules de lipides amphiphiles non-ioniques stabilisees. |
US5464696A (en) * | 1992-08-13 | 1995-11-07 | Bracco International B.V. | Particles for NMR imaging |
KR20010106462A (ko) * | 1998-09-01 | 2001-11-29 | 첎ìë² ì²Ž ê·žë ê³ ë¥Ž | 배늬ìŽë¥Œ ê°ë¡ì§ë¥ž ëì 칚í¬ì ì ì êž°ì ìŒë¡ ì ìŽëìì¡ |
US6080211A (en) * | 1999-02-19 | 2000-06-27 | Igen, Inc. | Lipid vesicle-based fuel additives and liquid energy sources containing same |
EP1264632A1 (de) * | 2001-06-08 | 2002-12-11 | Cognis Iberia, S.L. | Verwendung von Alkyl(ether)phosphaten(III) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2193871B1 (ja) * | 1972-07-25 | 1977-07-22 | Colgate Palmolive Co | |
SE408714B (sv) * | 1974-11-25 | 1979-07-02 | Berol Kemi Ab | Flytande vattenhaltigt tvett- och rengoringsmedel innehallande en ytaktiv del och komplexbildare |
FR2315991A1 (fr) * | 1975-06-30 | 1977-01-28 | Oreal | Procede de fabrication de dispersions aqueuses de spherules lipidiques et nouvelles compositions correspondantes |
FR2416008A1 (fr) * | 1978-02-02 | 1979-08-31 | Oreal | Lyophilisats de liposomes |
EP0102324A3 (de) * | 1982-07-29 | 1984-11-07 | Ciba-Geigy Ag | Lipide und Tenside in wÀssriger Phase |
-
1983
- 1983-09-29 JP JP58181628A patent/JPS6072830A/ja active Granted
-
1984
- 1984-09-07 GB GB08422629A patent/GB2151203B/en not_active Expired
- 1984-09-26 FR FR8414761A patent/FR2552666B1/fr not_active Expired
- 1984-09-27 DE DE19843435517 patent/DE3435517A1/de not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
GB2151203B (en) | 1987-01-07 |
FR2552666B1 (fr) | 1988-05-27 |
JPS6072830A (ja) | 1985-04-24 |
GB8422629D0 (en) | 1984-10-10 |
DE3435517A1 (de) | 1985-04-18 |
FR2552666A1 (fr) | 1985-04-05 |
GB2151203A (en) | 1985-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH0326166B2 (ja) | ||
JPH0326165B2 (ja) | ||
RU2136282C1 (ru) | ÐПМÑеМÑÑОÑПваММÑй вПЎМÑй ÑаÑÑÐ²ÐŸÑ Ð°ÑгаÑÑПбаМа | |
FR2597367A1 (fr) | Procede pour faciliter la formation de spherules lipidiques en dispersion dans une phase aqueuse et pour ameliorer leur stabilite et leur taux d'encapsulation, et dispersions correspondantes. | |
JPS6156016B2 (ja) | ||
JPS6242733A (ja) | ãªããœâã 圢æçšçµæç©ããã³åœ¢ææ¹æ³ | |
GB1587076A (en) | Injection solutions containing micelle-forming agents | |
FR2597345A1 (fr) | Composition cosmetique ou pharmaceutique a base d'une dispersion aqueuse de spherules lipidiques. | |
FR2988609A1 (fr) | Formulation pour l'hormonotherapie | |
CN104684543A (zh) | çšäºééèœè°èå¹²æ°rnaå æºæ§æºå¶çæ žè·é žåºåçå¶å | |
US6679822B2 (en) | Polyalkylene oxide-modified phospholipid and production method thereof | |
ITMI942142A1 (it) | Liposomi al chetoprofen | |
JP4480402B2 (ja) | ãªã³è質èªå°äœ | |
JP5588619B2 (ja) | ïœïŒšå¿çæ§ãªããœãŒã | |
DE3882984T2 (de) | Herstellung einer aus einem pharmakologischen wirkstoff und einem lipid bestehenden lösung. | |
JPS6072829A (ja) | ãã·ã¯ã«çšçµæç© | |
JP6297737B1 (ja) | æ£ã«åž¯é»ããè·é»ããªãœãŒã ã®èª¿è£œæ¹æ³åã³è·é»ããªãœãŒã | |
EP2763656B1 (fr) | Formulations pour le diagnostic et le traitement de cancers hormonodépendants et de cancers des organes de synthÚse d'hormones stéroïdiennes. | |
JPS6075434A (ja) | ãã·ã¯ã«çšçµæç© | |
JP4403303B2 (ja) | ãªã³è質èªå°äœåã³ãã®è£œé æ¹æ³ | |
JPH05186372A (ja) | èèªä¹³å€åã³ïœïœïœèšºæçšé åœ±å€ | |
JPS6172721A (ja) | ã€ã³ã·ãŠãªã³å«æãªããŸâã | |
EP0038512A1 (en) | Transdermal carrier materials | |
JPH10236920A (ja) | ä¹³åçµæç© | |
JPS60136508A (ja) | ãã·ã¯ã«çšçµæç© |